Chlorhexidine Cuts Umbilical Cord Infection & Newborn Deaths – Review

A simple antiseptic applied to the umbilical cord stump of newborns may significantly reduce the risk of infection and, potentially, death in low- and middle-income countries, according to a newly published review. The analysis, appearing in the Cochrane Database of Systematic Reviews, focuses on the use of chlorhexidine, a common antiseptic, and its impact on umbilical cord care.

Umbilical Cord Care: A Critical Window

After birth, the umbilical cord is clamped and cut, leaving a stump that needs to dry and fall off – typically within five to fifteen days. This period presents a vulnerability: the stump provides a potential entry point for bacteria. Infection of the umbilical cord, known as omphalitis, can range from localized skin irritation to a dangerous, body-wide infection called sepsis. Sepsis is particularly life-threatening in settings where hygiene is limited and access to healthcare is challenging.

The review examined data from 34 trials involving over 69,000 babies, conducted in both developed and developing nations. Researchers analyzed studies comparing different antiseptics – including chlorhexidine, alcohol, silver sulfadiazine, and povidone-iodine – with standard “dry cord care” (keeping the stump clean and dry) or no specific treatment. The focus was on assessing the impact of these interventions on mortality, cord infection rates, and the time it takes for the cord to separate.

Chlorhexidine Shows Promise, Especially in Resource-Limited Settings

The findings suggest that topical application of 4.0% chlorhexidine to the umbilical cord stump likely reduces the risk of cord infection. Specifically, the reduction in omphalitis ranged from 27% to 56% depending on the severity of infection, according to research published in the Cochrane Library here. The review also indicates a potential reduction in newborn mortality, though this effect was primarily observed in low- and middle-income countries. Interestingly, chlorhexidine application was also associated with a delay in cord separation, adding approximately 1.7 days to the process.

The benefits of chlorhexidine appear less clear in high-income countries, where maintaining a clean and dry cord stump may be sufficient. The evidence for other antiseptics, such as alcohol and silver sulfadiazine, remains limited and inconclusive, particularly in low- and middle-income settings.

Understanding the Evidence: Trial Design and Limitations

It’s important to understand the nature of the evidence. The review included a mix of study designs, including randomized controlled trials and cluster-randomized trials. Many of the studies conducted in hospitals, primarily in developed countries, while a smaller number were conducted in community settings in developing countries. This difference in setting is crucial, as the risk of umbilical cord infection and the potential benefits of antiseptics are likely to vary significantly based on hygiene conditions and access to healthcare.

The researchers also noted a high degree of variability (heterogeneity) across the included studies, meaning that the results were not entirely consistent. This variability could be due to differences in study populations, antiseptic application methods, and the definition of omphalitis. The review authors acknowledge that these factors limit the certainty of the findings and highlight the require for further research.

What Does This Mean for Newborn Care?

The findings support the World Health Organization’s (WHO) recommendation for chlorhexidine umbilical cord care in settings with high rates of neonatal mortality and limited access to clean delivery practices. Cochrane’s summary emphasizes that this intervention is likely to be most effective where the risk of infection is highest. However, it’s crucial to remember that chlorhexidine is not a substitute for good hygiene practices, including clean delivery and proper handwashing.

For parents in high-income countries, the current recommendation remains to keep the umbilical cord stump clean and dry. Avoid using alcohol or other antiseptics unless specifically advised by a healthcare professional. Contact a doctor if you notice any signs of infection, such as redness, swelling, pus, or a foul odor around the cord stump.

Risk in Context: Absolute vs. Relative Reduction

While a 27% to 56% reduction in omphalitis sounds substantial, it’s important to consider the baseline risk of infection. In high-income countries, the incidence of umbilical cord infection is relatively low, meaning that even a significant relative reduction may translate to a minor absolute reduction in the number of cases. In contrast, in low- and middle-income countries, where the risk of infection is higher, the same relative reduction could have a much larger impact on public health.

The Ongoing Process of Evidence Evaluation

The Cochrane review is not a final answer, but rather a synthesis of the best available evidence at a given point in time. The researchers emphasize the need for ongoing surveillance and further research to refine our understanding of optimal umbilical cord care practices. This includes conducting more rigorous trials in diverse settings, investigating the long-term effects of chlorhexidine application, and exploring the potential benefits of other antiseptic agents. The WHO regularly updates its guidelines based on new evidence, and healthcare professionals should stay informed about the latest recommendations.

Next Steps: Continued Monitoring and Research

The Cochrane Collaboration plans to update this review as new evidence becomes available. Ongoing community trials are also underway to further assess the effectiveness of chlorhexidine in real-world settings. Public health organizations will continue to monitor rates of neonatal sepsis and omphalitis to identify areas where interventions are most needed and to evaluate the impact of existing programs. Parents and caregivers should remain vigilant for signs of infection and seek medical attention promptly if concerns arise.